logo
Select company
Select metric
$ 13KGross Profit
VS
Market
13
Sector
33
Industry
49
History
16
$ 2.36Close
$ 2 - $ 2.7 52-Week Range
Ticker Information

Ticker

ORMP

Company Name

ORAMED PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ORAMED PHARMACEUTICALS INC - Gross Profit Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ORMP - GP Historical data
DateGross Profit
6/30/2025$ 13K
3/31/2025$ 13K
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 674K
12/31/2023$ 1.34M
9/30/2023$ 2.02M
6/30/2023$ 2.7M
3/31/2023$ 2.7M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ORAMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) GP stands at $ 2.71M.
  • Over the past 5 years, ORAMED PHARMACEUTICALS INC's average GP has been $ 1.74M.
  • The median GP for ORAMED PHARMACEUTICALS INC during this period was $ 2.7M
  • ORAMED PHARMACEUTICALS INC reached its highest GP over the past 5 years at $ 2.93M.
  • The lowest GP recorded by ORAMED PHARMACEUTICALS INC in the same timeframe $ 0

ORAMED PHARMACEUTICALS INC's GP vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GP Benchmarks
CompanyGP
NTRB : NUTRIBAND INC $ 885.84KOTLK : OUTLOOK THERAPEUTICS INC $ 1.07MCNTB : CONNECT BIOPHARMA HOLDINGS LTD $ 1.97MPYXS : PYXIS ONCOLOGY INC $ 2.82MBTAI : BIOXCEL THERAPEUTICS INC $ -1.25MVTGN : VISTAGEN THERAPEUTICS INC $ 646KDTIL : PRECISION BIOSCIENCES INC $ 1.26MLGVN : LONGEVERON INC $ 1.63MPLUR : PLURI INC $ 654KADVM : ADVERUM BIOTECHNOLOGIES INC $ 1M

Definition of Gross Profit

[Income Statement] Gross Profit is a financial metric that demonstrates how sales [Revenue] cover the direct costs associated with the production of goods [CoR].

ORMP - Gross Profit, Last 5 years

$ 0

Minimum

Jun 30, 2024

$ 2.93M

Maximum

Sep 30, 2022

$ 1.74M

Average

$ 2.7M

Median

GP Benchmark Analysis

The chart above depicts the distribution of GP for companies in the Total Stock Market. The average GP of the companies is $ 245.83M with a standard deviation of $ 328.78M.
The following table provides additional summary stats:
GP in the Market:
filtered constituents3.34K
min$ -790.38M
max$ 1.32B
average$ 245.83M
median$ 93.51M
std$ 328.78M